Edge Therapeutics Competitors and Similar CompaniesClear all
Edge Therapeutics's competitors and similar companies include Ipsen, Biogen, Cadila Pharmaceuticals and Livzon Pharmaceutical Group.
 Edge Therapeutics Edge Therapeutics, a clinical-stage biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2009 | Founding Date 1929 | Founding Date 1978 | Founding Date 1951 | Founding Date 1985 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Berkeley Heights, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | |
Employees | Employees 10 | Employees 5,358 | Employees 7,605 | Employees 8,5201% increase | Employees 9,067 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 10.2 b | Valuation ($) 26.7 b | Valuation ($) N/A | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €659.1m (FY, 2025) | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit $7.5b (FY, 2025) | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income ($16.9m) (FY, 2021) | Net income €445.1m (FY, 2025) | Net income $1.3b (FY, 2025) | Net income N/A | Net income ¥2.4b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyCadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company